Skip to Content

ISI Announces Regional eCTD Readiness Workshops for Electronic Submissions

WHIPPANY, NJ (July 12, 2007) – Image Solutions Inc., (ISI), a leader in providing software and service solutions to support the drug development lifecycle, announced today that it will continue its series of workshops in the United States on the electronic Common Technical Document (eCTD), offering best practices oriented training in hotbed areas on the West Coast and in the Northeast.

Throughout the workshop, discussions will focus on how to overcome the challenges of the eCTD by understanding technical and process-related pitfalls, transition pain-points and quality control recommendations. With more than 400 successful eCTD submissions to its name, ISI remains committed to passing on field-tested experience and lessons learned to workshop participants. The topics in this workshop are presented by expert trainers who are grounded in years of successful submissions.

Participants also receive a 300-page eCTD Readiness Workbook with critical industry information and ISI’s lessons learned on eCTD preparation and how to move towards eCTD readiness efficiently. Workshops held at ISI headquarters office in Whippany, NJ will be held in newly constructed classrooms with state of the art computers and training technology.
Dates and Locations:
• San Diego, CA. July 24-25, 2007
• San Francisco, CA. July 26-27, 2007

Individuals interested in attending the workshop can register on our web site at, or by contacting Keith Ward at ISI,, or calling 866-827-5827. 
About Image Solutions, Inc.

Founded in 1992, Image Solutions, Inc (ISI) is a proven market leader in providing submissions solutions, process services and consulting to Life Sciences companies as a way to improve clinical and regulatory processes that bring new medicines to market. ISI was among the first professional services firm to deliver electronic submissions to the industry and since has delivered nearly 1,000 electronic submissions and 400 eCTD submissions. ISI serves the top 50 pharmaceutical and biotech organizations as well as the top companies in other regulated industries.

ISI is a privately held company with headquarters in Whippany, New Jersey and operations throughout the U.S., Europe and Asia. ISI also remains committed to giving back to society and sharing its success with others by donating 10 percent of annual net profits to over 20 recognized charitable organizations. For more information, visit the company website at:

Press Contacts:
Lisa Meyer  
Director, Global Marketing  
973-560-0808 x. 217        

Kurt Rossler 
M Booth & Associates  
212 481-7000

Posted: July 2007